Florida Attorney General Issues Emergency Rule Banning Chemically Manipulated 7-OH Products Ahead of Federal Action

Why it matters

Florida's emergency action against concentrated 7-OH — taken weeks before the DEA filed its federal notice — established a state-level template for distinguishing between botanical kratom and chemically manipulated opioid products, without restricting natural kratom leaf.

The big picture

Florida is home to some of the largest 7-OH manufacturers and distributors in the country. AG Uthmeier's emergency rule arrived over active industry lobbying against restrictions and preceded federal action by about two weeks. The Florida model — targeting chemistry, not the botanical plant — is now the framework DEA's scheduling notice also adopted, suggesting state and federal approaches have converged on the same legal distinction.

Key findings

• Florida AG James Uthmeier issued an emergency rule targeting chemically manipulated 7-OH opioid products and their derivatives in Florida
• The rule specifically targets concentrated 7-OH; natural kratom leaf remains legal in Florida
• Some of the largest 7-OH manufacturers operate in Florida and had actively lobbied against the restrictions
• HHS and FDA recommended federal scheduling action against 7-OH in 2025; Congressional appropriators expressed grave concern about chemically manipulated products marketed as kratom
• The AKA noted trace 7-OH in natural kratom and high-potency chemically converted 7-OH are pharmacologically distinct products

What they say

"Florida has demonstrated that policymakers do not have to choose between protecting consumers and preserving access to natural kratom. They can do both." — Mac Haddow, American Kratom Association

Bottom line

Florida AG Uthmeier's emergency rule against concentrated 7-OH, issued before the DEA filed its federal notice, is an early proof that state-level enforcement can draw a meaningful legal line between botanical kratom and dangerous semi-synthetic derivatives.